View in EDS HTML Full Text PDF Full Text

Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma.

Saved in:
Bibliographic Details
Title: Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma.
Authors: Shimauchi T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan., Murai J; Division of Cell Growth and Tumor Regulation, Proteo-Science Center, Toon, Ehime, 791-0295, Japan.; Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Ehime, 791-0295, Japan., Iwasaki M; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan., Phadungsaksawasdi P; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan., Ojima T; Department of Community Health and Preventive Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192 Japan., Fujii K; Department of Dermatology, Kindai University Hospital, Osaka, 589-8511, Japan., Honda T; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
Source: NAR cancer [NAR Cancer] 2025 Oct 07; Vol. 7 (4), pp. zcaf037. Date of Electronic Publication: 2025 Oct 07 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101769553 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-8674 (Electronic) Linking ISSN: 26328674 NLM ISO Abbreviation: NAR Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41064808
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Shimauchi+T%22">Shimauchi T</searchLink>; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.<br /><searchLink fieldCode="AU" term="%22Murai+J%22">Murai J</searchLink>; Division of Cell Growth and Tumor Regulation, Proteo-Science Center, Toon, Ehime, 791-0295, Japan.; Department of Biochemistry and Molecular Genetics, Ehime University Graduate School of Medicine, Toon, Ehime, 791-0295, Japan.<br /><searchLink fieldCode="AU" term="%22Iwasaki+M%22">Iwasaki M</searchLink>; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.<br /><searchLink fieldCode="AU" term="%22Phadungsaksawasdi+P%22">Phadungsaksawasdi P</searchLink>; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.<br /><searchLink fieldCode="AU" term="%22Ojima+T%22">Ojima T</searchLink>; Department of Community Health and Preventive Medicine, Hamamatsu University School of Medicine, Hamamatsu, 431-3192 Japan.<br /><searchLink fieldCode="AU" term="%22Fujii+K%22">Fujii K</searchLink>; Department of Dermatology, Kindai University Hospital, Osaka, 589-8511, Japan.<br /><searchLink fieldCode="AU" term="%22Honda+T%22">Honda T</searchLink>; Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, 431-3192, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101769553%22">NAR cancer</searchLink> [NAR Cancer] 2025 Oct 07; Vol. 7 (4), pp. zcaf037. <i>Date of Electronic Publication: </i>2025 Oct 07 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101769553 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2632-8674 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226328674%22">26328674 </searchLink><i>NLM ISO Abbreviation: </i>NAR Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41064808
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/narcan/zcaf037
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: zcaf037
    Titles:
      – TitleFull: Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Shimauchi T
      – PersonEntity:
          Name:
            NameFull: Murai J
      – PersonEntity:
          Name:
            NameFull: Iwasaki M
      – PersonEntity:
          Name:
            NameFull: Phadungsaksawasdi P
      – PersonEntity:
          Name:
            NameFull: Ojima T
      – PersonEntity:
          Name:
            NameFull: Fujii K
      – PersonEntity:
          Name:
            NameFull: Honda T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 07
              M: 10
              Text: 2025 Oct 07
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2632-8674
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: NAR cancer
              Type: main
ResultId 1